Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Outlook Therapeutics (OTLK) Other Gross PP&E Adjustments (2016 - 2025)

Outlook Therapeutics (OTLK) has disclosed Other Gross PP&E Adjustments for 8 consecutive years, with -$670807.0 as the latest value for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 45.99% to -$670807.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$670807.0, a 45.99% increase, with the full-year FY2025 number at -$421131.0, changed N/A from a year prior.
  • Other Gross PP&E Adjustments was -$670807.0 for Q4 2025 at Outlook Therapeutics, down from -$421131.0 in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of -$421131.0 in Q3 2025 to a low of -$1.2 million in Q4 2024.